Febarbamate

Source: Wikipedia, the free encyclopedia.
Febarbamate
Clinical data
Other namesMS-543
ATC code
Identifiers
  • [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-
    diazinan-1-yl)propan-2-yl] carbamate
JSmol)
  • C1(=O)NC(C(C(=O)N1CC(OC(=O)N)COCCCC)(C2=CC=CC=C2)CC)=O
  • InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27) checkY
  • Key:QHZQILHUJDRDAI-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Febarbamate (

formulation called tetrabamate.[1][2][3][4]

See also

References

  1. ^ World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
  2. ISBN 978-3-88763-075-1
    . Retrieved 26 November 2011.
  3. PMID 5016064
    .
  4. ISBN 978-0-7514-0499-9
    . Retrieved 26 November 2011.
musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Febarbamate&oldid=1188722862"